top of page

Tralesinidase Alfa Pre-Clinical Publications

Related Posts

See All

We believe that intracerebroventricular enzyme replacement therapy holds exciting potential to treat rare pediatric neurological diseases, including GM1 Gangliosidosis, which is in our pre-clinical de

Screen Shot 2021-01-25 at 4.58.05 PM.png
bottom of page